Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 465

1.

Anesthetic considerations for magnetic seizure therapy: a novel therapy for severe depression.

White PF, Amos Q, Zhang Y, Stool L, Husain MM, Thornton L, Downing M, McClintock S, Lisanby SH.

Anesth Analg. 2006 Jul;103(1):76-80, table of contents.

PMID:
16790630
2.

Bilateral bispectral index monitoring during and after electroconvulsive therapy compared with magnetic seizure therapy for treatment-resistant depression.

Soehle M, Kayser S, Ellerkmann RK, Schlaepfer TE.

Br J Anaesth. 2014 Apr;112(4):695-702. doi: 10.1093/bja/aet410. Epub 2013 Dec 3.

PMID:
24305645
3.

Magnetic seizure therapy of treatment-resistant depression in a patient with bipolar disorder.

Kayser S, Bewernick B, Axmacher N, Schlaepfer TE.

J ECT. 2009 Jun;25(2):137-40. doi: 10.1097/YCT.0b013e31817dc45a.

PMID:
19057399
4.

Can the bispectral index be used to predict seizure time and awakening after electroconvulsive therapy?

White PF, Rawal S, Recart A, Thornton L, Litle M, Stool L.

Anesth Analg. 2003 Jun;96(6):1636-9, table of contents.

PMID:
12760987
5.

The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy.

Avramov MN, Husain MM, White PF.

Anesth Analg. 1995 Sep;81(3):596-602.

PMID:
7653829
7.
8.

Antidepressant effects, of magnetic seizure therapy and electroconvulsive therapy, in treatment-resistant depression.

Kayser S, Bewernick BH, Grubert C, Hadrysiewicz BL, Axmacher N, Schlaepfer TE.

J Psychiatr Res. 2011 May;45(5):569-76. doi: 10.1016/j.jpsychires.2010.09.008. Epub 2010 Oct 16.

PMID:
20951997
9.
10.

The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysis.

McLoughlin DM, Mogg A, Eranti S, Pluck G, Purvis R, Edwards D, Landau S, Brown R, Rabe-Heskith S, Howard R, Philpot M, Rothwell J, Romeo R, Knapp M.

Health Technol Assess. 2007 Jul;11(24):1-54.

11.
12.

Effects of remifentanil and alfentanil on seizure duration, stimulus amplitudes and recovery parameters during ECT.

Akcaboy ZN, Akcaboy EY, Yigitbasł B, Bayam G, Dikmen B, Gogus N, Dilbaz N.

Acta Anaesthesiol Scand. 2005 Sep;49(8):1068-71.

PMID:
16095445
13.

Effects of nicardipine and labetalol on the acute hemodynamic response to electroconvulsive therapy.

Avramov MN, Stool LA, White PF, Husain MM.

J Clin Anesth. 1998 Aug;10(5):394-400.

PMID:
9702620
14.

Update on magnetic seizure therapy: a novel form of convulsive therapy.

Lisanby SH.

J ECT. 2002 Dec;18(4):182-8. Review.

PMID:
12468992
15.

Bispectral index as an indicator of seizure inducibility in electroconvulsive therapy under thiopental anesthesia.

Ochiai R, Yamada T, Kiyama S, Nakaoji T, Takeda J.

Anesth Analg. 2004 Apr;98(4):1030-5, table of contents.

PMID:
15041593
16.

Comparable seizure characteristics in magnetic seizure therapy and electroconvulsive therapy for major depression.

Kayser S, Bewernick BH, Hurlemann R, Soehle M, Schlaepfer TE.

Eur Neuropsychopharmacol. 2013 Nov;23(11):1541-50. doi: 10.1016/j.euroneuro.2013.04.011. Epub 2013 Jun 29.

PMID:
23820052
17.
18.

The effect of remifentanil on seizure duration and acute hemodynamic responses to electroconvulsive therapy.

Recart A, Rawal S, White PF, Byerly S, Thornton L.

Anesth Analg. 2003 Apr;96(4):1047-50, table of contents.

PMID:
12651657
19.

Dexmedetomidine blunts acute hyperdynamic responses to electroconvulsive therapy without altering seizure duration.

Begec Z, Toprak HI, Demirbilek S, Erdil F, Onal D, Ersoy MO.

Acta Anaesthesiol Scand. 2008 Feb;52(2):302-6. Epub 2007 Nov 1.

PMID:
17976228
20.

Etomidate anesthesia increases seizure duration during ECT. A retrospective study.

Trzepacz PT, Weniger FC, Greenhouse J.

Gen Hosp Psychiatry. 1993 Mar;15(2):115-20.

PMID:
8472938

Supplemental Content

Support Center